GENE ONLINE|News &
Opinion
Blog

CAR-T Cell
Overcoming Immune Evasion in CAR-T Therapies with Groundbreaking New Discoveries
2022-09-22
Roche Dives Deeper into Off-The-Shelf Cell Therapies in Poseida Partnership
2022-08-04
Gene & Cell Therapy’s Big Leaps in the Past 5 Years
2022-07-08
Novartis CAR-T Cell Therapy Receives FDA Approval for Third Indication to Treat Follicular Lymphoma
2022-05-30
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
Boston’s Kelonia Therapeutics Bags $50M to Accelerate Genetic Medicines
2022-04-29
Assembling the Aging Trajectory of Immune Cells with Single Cell Sequencing
2022-04-22
AACR 2022: Stand Up to Cancer, Standing up to Treatment
2022-04-21
FDA Announces Draft Guidances on Genome Editing and CAR T Cell Therapy
2022-03-25
Bristol-Myers Squibb’s Abecma Becomes First Approved CAR T-Cell Therapy for Multiple Myeloma in Japan
2022-01-24
ASH 2021: Engineering Stem Cells into Therapeutic Immune Cells
2021-12-21
ASH 2021: 4 Immunotherapies Highlight Transformations in Blood Cancer Treatment
2021-12-13
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
China’s Legend Biotech to Build a CAR-T Therapy Production Site in Belgium
2021-06-24
1 2 3
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!